Facebook Instagram Pinterest Reddit Tumblr Twitter Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 200

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

The Psychedelic News Feed: January 19 – 25, 2025

“Changes Are Never Linear”: Joost Breeksema on the Human Side of Psychedelic Therapy

Op-Ed: From Psychedelic Prohibition to Psychedelic Public Health

Pα+ Psychedelic Bulletin #218: FDA’s Farchione Says Psychedelic INDs Are “a Third” of Her Workload; Ipsos/Psychedelic Alpha Poll; Reunion Eyes Single Phase 3 in...

Joshua White – Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support

PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara...

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences...

Two esteemed doctors join CB Therapeutics in its exploration of innovative...

Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles...

MYND Life Sciences Acquires Rights for the Use of Psychedelics to...

PTSF89 – A Macro Dive Into Microdosing

MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult...

COMPASS Selected for Addition to NASDAQ Biotechnology Index

Entheon Biomedical Announces EEG Patent Application & Provides Research Update

MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent...

1...199200201...307Page 200 of 307

EDITOR PICKS

The Psychedelic News Feed: January 19 – 25, 2025

“Changes Are Never Linear”: Joost Breeksema on the Human Side of...

Op-Ed: From Psychedelic Prohibition to Psychedelic Public Health

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr Twitter Youtube
    ©